Pathology
 |
|
16 january 2019 21:00:04 |
| Tyrosine kinase inhibitor levels matter in treating chronic GVHD (Bone Marrow Transplantation) |
|
Tweet |
| 72 viewsCategory: Medicine, Pathology |
 Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells (Bone Marrow Transplantation)Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromes (Bone Marrow Transplantation) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
